$300.26 $0.87 (0.3%)

04:00 PM EST on 12/06/19

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 4 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $300.26 Mkt Cap $54.2B
Open $299.68 P/E Ratio 10.72
Prev. Close $299.39 Div. (Yield) $0.00 (0.0%)
Daily Range $299.68 - $304.56 Volume 2,240,487
52-Wk Range $215.78 - $344.00 Avg. Daily Vol. 2,581,787

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

989 Outperform
74 Underperform
 

All-Star Players

229 Outperform
14 Underperform
 

Wall Street

16 Outperform
1 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (97.32)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (25.21)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar StocksForLimits (< 20) Submitted: 3/25/2019 11:51:17 AM : Outperform Start Price: $218.70 NASDAQ:BIIB Score: +24.59

worth a shot here... technically, a big gap to work into from down here ...

Recs

0
Member Avatar Stoic (54.68) Submitted: 2/9/2019 1:55:33 PM : Outperform Start Price: $316.12 NASDAQ:BIIB Score: -21.11

Cheap, big insider buying.

Recs

0
Member Avatar rjs157 (78.13) Submitted: 11/5/2018 1:52:50 PM : Outperform Start Price: $317.91 NASDAQ:BIIB Score: -20.91

Cambridge, MA - based drug company poised for growth.

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (97.32) Score: +622.39

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey 25.70 4/12/2007 Outperform 3Y $43.64 +588.04% +131.58% +456.46 1 Comment
anewday101 91.39 3/5/2007 Outperform 1Y $43.36 +592.48% +142.29% +450.19 0 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +583.19% +137.27% +445.92 0 Comment
tradersinsights 75.31 4/10/2007 Outperform 1Y $44.42 +575.96% +130.35% +445.61 1 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +603.51% +158.58% +444.94 1 Comment
mtung 42.85 3/8/2007 Outperform NS $44.10 +580.86% +137.78% +443.08 0 Comment
owen1000 89.96 8/22/2006 Outperform 3Y $42.83 +601.05% +158.20% +442.85 0 Comment
apple1jam 78.25 3/6/2007 2/27/2008 Outperform NS $43.94 +583.34% +140.80% +442.54 0 Comment
sweetpeajack 71.34 9/20/2006 Outperform 3Y $43.38 +592.16% +152.70% +439.46 0 Comment
mgroeber 61.00 4/9/2007 Outperform NS $44.86 +569.33% +130.12% +439.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.